Position in APGE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$242,630
New position
Shares Held
1,828
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#228
of 285 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Independent Advisor Alliance holds $7,993,707 across 26 Biotechnology names. APGE ranks #11 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABSI |
Absci Corp
|
153,855 | $1,783,179 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,935 | $1,457,902 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
25,436 | $666,931 | |
| 4 | INCY |
Incyte Corp
|
5,512 | $624,840 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
8,844 | $482,350 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
753 | $469,525 | |
| 7 | HELP |
Cybin Inc.
|
69,933 | $462,257 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
1,679 | $314,442 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,630 | 1,828 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||